浏览全部资源
扫码关注微信
1.深圳市妇幼保健院药剂科,广东 深圳 518028
2.南京大学医学院附属鼓楼医院药学部,南京 210008
3.南京大学医学院附属鼓楼医院胰腺与代谢外科,南京 210008
药师,硕士。研究方向:围手术期营养管理。E-mail:wanglina668@163.com
副主任药师。研究方向:肠内营养与肠外营养。 E-mail:18061678828@189.cn
纸质出版日期:2024-03-15,
收稿日期:2023-07-12,
修回日期:2023-12-14,
扫 描 看 全 文
王黎娜,卞晓洁,蒋绍艳等.临床药师参与胰十二指肠切除围手术期营养管理的效果评价 Δ[J].中国药房,2024,35(05):618-622.
WANG Lina,BIAN Xiaojie,JIANG Shaoyan,et al.Evaluation of clinical pharmacists participating in the perioperative nutritional management of pancreaticoduodenectomy[J].ZHONGGUO YAOFANG,2024,35(05):618-622.
王黎娜,卞晓洁,蒋绍艳等.临床药师参与胰十二指肠切除围手术期营养管理的效果评价 Δ[J].中国药房,2024,35(05):618-622. DOI: 10.6039/j.issn.1001-0408.2024.05.19.
WANG Lina,BIAN Xiaojie,JIANG Shaoyan,et al.Evaluation of clinical pharmacists participating in the perioperative nutritional management of pancreaticoduodenectomy[J].ZHONGGUO YAOFANG,2024,35(05):618-622. DOI: 10.6039/j.issn.1001-0408.2024.05.19.
目的
2
探讨临床药师参与胰十二指肠切除术(PD)围手术期营养规范管理对患者预后的影响。
方法
2
回顾性分析2019年11月-2021年2月在南京大学医学院附属鼓楼医院胆胰外科行PD的100例患者的临床资料,按围手术期营养管理方案的不同,将其分为临床药师干预组(
n
=51,临床药师根据营养管理规范流程进行干预)和对照组(
n
=49,临床药师仅术前进行营养评估,临床医师根据患者病情进行营养支持),评价两组患者术后恢复指标、经济性评价指标、住院时长、术后并发症、术后肠内营养支持途径等结局指标的差异。
结果
2
临床药师干预组患者术后恢复流质饮食时间、术后首次通气时间、术后首次通便时间、腹腔引流管拔出时间均显著早于对照组(
P
<0.05),住院费用、药物费用、营养支持费用、肠外营养费用、白蛋白制剂费用、术后住院天数均显著低于/短于对照组(
P
<0.05);两组患者术后并发症发生率差异无统计学意义(
P
>0.05);两组患者围手术期肠内营养支持途径比较,差异有统计学意义(
P
<0.05)。
结论
2
临床药师参与PD围手术期营养管理可显著降低患者的住院费用、营养支持费用,改善患者围手术期的营养状况、缩短其住院时间。
OBJECTIVE
2
To explore the role of clinical pharmacists participating in the standardized perioperative nutritional management process for pancreaticoduodenectomy (PD) on improving postoperative recovery in patients.
METHODS
2
The clinical data of 100 patients undergoing PD in the Department of Biliary and Pancreatic Surgery, Drum Tower Hospital Affiliated to Nanjing University School of Medicine from November 2019 to February 2021 were analyzed retrospectively. According to the different perioperative nutrition management plans, they were divided into clinical pharmacist intervention group (
n
=51, clinical pharmacists intervened according to the standardized nutrition management process) and control group (
n
=49, clinical pharmacists only performed preoperative nutrition evaluation, and clinical physicians took nutrition support according to the patient’s condition). The differences in postoperative recovery index, economic evaluation index, hospitalization length, postoperative complications, and postoperative enteral nutrition support route were compared between 2 groups.
RESULTS
2
The time of postoperative diet, the first postoperative ventilation, the first postoperative defecation, and postoperative drainage time of abdominal drain were significantly earlier in the clinical pharmacist intervention group than in the control group (
P
<0.05); the hospitalization cost, medication cost, nutritional support cost, parenteral nutrition cost, albumin preparation cost, and the length of postoperative hospitalization were significantly lower/shorter in the clinical pharmacist intervention group than in the control group (
P
<0.05); there was no statistically significant difference in the incidence of postoperative complications between the two groups (
P
>0.05); there was statistically significant difference in the perioperative enteral nutrition support pathways between two groups (
P
<0.05).
CONCLUSIONS
2
Clinical pharmacists’ participation in perioperative nutritional management for PD can significantly reduce hospitalization costs and nutritional support costs, improve patients’ perioperative nutritional status, and shorten hospital stays.
胰十二指肠切除术围手术期临床药师营养管理
perioperativeclini- cal pharmacistnutritional management
HUANG J J,LOK V,NGAI C H,et al. Worldwide burden of,risk factors for,and trends in pancreatic cancer[J]. Gastroenterology,2021,160(3):744-754.
BRAY F,FERLAY J,SOERJOMATARAM I,et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424.
MIZRAHI J D,SURANA R,VALLE J W,et al. Pancreatic cancer[J]. Lancet,2020,395(10242):2008-2020.
SMITS F J,VERWEIJ M E,DAAMEN L A,et al. Impact of complications after pancreatoduodenectomy on mortality,organ failure,hospital stay,and readmission:analysis of a nationwide audit[J]. Ann Surg,2022,275(1):e222-e228.
NAKEEB A E,ASKAR W,ATEF E,et al. Trends and outcomes of pancreaticoduodenectomy for periampullary tumors:a 25-year single-center study of 1 000 consecutive cases[J]. World J Gastroenterol,2017,23(38):7025-7036.
王新颖,李宁,黎介寿. 规范化营养支持在外科治疗中的地位[J]. 外科理论与实践,2014,19(1):16-20.
WANG X Y,LI N,LI J S. The position of standardized nutritional support in surgical treatment[J]. J Surg Concepts Pract,2014,19(1):16-20.
ABE T,NAKATA K,KIBE S,et al. Prognostic value of preoperative nutritional and immunological factors in patients with pancreatic ductal adenocarcinoma[J]. Ann Surg Oncol,2018,25(13):3996-4003.
GIANOTTI L,BESSELINK M G,SANDINI M,et al. Nutritional support and therapy in pancreatic surgery:a position paper of the International Study Group on Pancreatic Surgery(ISGPS)[J]. Surgery,2018,164(5):1035-1048.
许静涌,卫积书,崔红元,等. 胰十二指肠切除围术期营养管理的调查研究:附全国64家三甲医院报告[J]. 中华消化外科杂志,2020,19(10):1062-1069.
XU J Y,WEI J S,CUI H Y,et al. A nationwide survey of perioperative nutritional management of patients under- going pancreatoduo denectomy:a report from 64 level A tertiary hospitals[J]. Chin J Dig Surg,2020,19(10):1062-1069.
王黎娜,卞晓洁,陈大宇,等. 不同营养风险筛查方法对胰十二指肠切除患者适用性的对比[J]. 中南药学,2021,19(4):756-761.
WANG L N,BIAN X J,CHEN D Y,et al. Different nutrition screening methods for patients undergoing pancreaticoduodenectomy[J]. Cent South Pharm,2021,19(4):756-761.
中华医学会外科学分会胰腺外科学组,中华医学会肠外肠内营养学分会. 胰腺外科围术期全程化营养管理中国专家共识:2020版[J]. 中华消化外科杂志,2020,19(10):1013-1029.
Pancreatic Surgery Group of Surgery Branch of Chinese Medical Association,Extracorporeal and Enteral Nutrition Branch of the Chinese Medical Association.Chinese expert consensus on perioperative whole-course nutrition management for pancreatic surgery:2020 edition[J]. Chin J Dig Surg,2020,19(10):1013-1029.
中华医学会外科学分会,中华医学会麻醉学分会. 加速康复外科中国专家共识及路径管理指南:2018版[J]. 中国实用外科杂志,2018,38(1):1-20.
Chinese Medical Association Surgery Branch,Chinese Medical Association Anesthesiology Branch.Expert consensus and path management guide for accelerated rehabilitation surgery in China:2018 edition[J]. China Ind Econ,2018,38(1):1-20.
宋春花,王昆华,郭增清,等. 中国常见恶性肿瘤患者营养状况调查[J]. 中国科学:生命科学,2020,50(12):1437-1452.
SONG C H,WANG K H,GUO Z Q,et al. Investigation of nutritional status in Chinese patients with common cancer[J]. Sci Sin Vitae,2020,50(12):1437-1452.
谈善军,虞文魁,林志亮,等. 早期肠内营养对胰十二指肠切除术后病人预后影响的Meta分析[J]. 肠外与肠内营养,2016,23(1):12-17,20.
TAN S J,YU W K,LIN Z L,et al. Meta-analysis of the effect of early enteral nutrition on the prognosis of patients after pancreaticoduodenectomy[J]. Parenter Enter Nutr,2016,23(1):12-17,20.
徐军辉,丁佑铭,汪斌,等. 胰十二指肠切除术后早期营养支持治疗方式的比较[J]. 肠外与肠内营养,2013,20(4):228-230.
XU J H,DING Y M,WANG B,et al. A comparative research for postoperative early enteral nutrition in patients of pancreatiodudenectomy[J]. Parenter Enter Nutr,2013,20(4):228-230.
顾小静. 全程化营养管理模式在胰腺癌患者中的应用[D]. 武汉:武汉轻工大学,2021.
GU X J. Application of whole-course nutrition management in patients with pancreatic cancer[D].Wuhan:Wuhan Polytechnic University,2021.
陈大宇,卞晓洁,刘金春,等. 肝癌肝切除围术期的规范化营养药物治疗服务模式的研究[J]. 药学与临床研究,2021,29(3):193-198.
CHEN D Y,BIAN X J,LIU J C,et al. Standardized nutrition medication therapy procedure during perioperative period of hepatic resection surgery[J]. Pharm Clin Res,2021,29(3):193-198.
ROBERTS K J,BANNISTER C A,SCHREM H. Enzyme replacement improves survival among patients with pancreatic cancer:results of a population based study[J]. Pancreatology,2019,19(1):114-121.
0
浏览量
5
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构